Latest statistics and disclosures from RHO CAPITAL PARTNERS's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IL, Anacor Pharmaceuticals In, RLOC, GNVC. These five stock positions account for 100.00% of RHO CAPITAL PARTNERS's total stock portfolio.
- Reduced shares in these 3 stocks: Anacor Pharmaceuticals In (-$26.07M), IL, .
- Sold out of its positions in VRNM.
- As of Dec. 31, 2013, RHO CAPITAL PARTNERS has $195.19M in assets under management (AUM). Assets under management grew from a total value of $163.01M to $195.19M.
- Independent of market fluctuations, RHO CAPITAL PARTNERS was a net seller by $30.85M worth of stocks in the most recent quarter.
RHO CAPITAL PARTNERS portfolio companies for December 2013 quarter
Past 13F-HR SEC Filings for RHO CAPITAL PARTNERS
- RHO CAPITAL PARTNERS 2013 Q3 - filed Nov. 7, 2013
- RHO CAPITAL PARTNERS 2013 Q2 - filed Aug. 13, 2013
- Rho Capital Partners 2013 Q1 - filed April 19, 2013
- Rho Capital Partners 2012 Q4 - filed Feb. 6, 2013
- Rho Capital Partners 2012 Q3 - filed Oct. 24, 2012
- Rho Capital Partners 2012 Q2 - filed Aug. 7, 2012
- Rho Capital Partners 2012 Q1 - filed May 11, 2012
- Rho Capital Partners 2011 Q4 - filed Feb. 7, 2012
- Rho Capital Partners 2011 Q3 - filed Nov. 7, 2011
- Rho Capital Partners 2011 Q2 - filed Aug. 9, 2011
- Rho Capital Partners 2011 Q1 - filed April 19, 2011
- Rho Capital Partners 2010 Q4 - filed March 1, 2011